APOC1 and Alzheimer disease: As ε4 dosage is included in the GWAS model it is not significantly associated with AAO of AD in this study, though the APOC1 variant on 19q13.32 is on the same haplotype in both the discovery and replication data sets (Figure S14 in supporting information).